Brr Op Co, LLC Guardant Health, Inc. Transaction History

Brr Op Co, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$98.77 - $132.17 $266,679 - $356,858	-2,700 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$127.04 - $179.1 $343,008 - $483,570	2,700 New	2,700 $412,000
Q4 2020 Feb 10, 2021	SELL	$99.96 - $135.93 $269,892 - $367,011	-2,700 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$60.49 - $97.5 $163,323 - $263,250	2,700 New	2,700 $219,000
Q1 2020 May 07, 2020	SELL	$59.04 - $88.81 $159,408 - $239,787	-2,700 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$59.49 - $82.78 $160,623 - $223,506	2,700 New	2,700 $211,000
Q3 2019 Nov 12, 2019	SELL	$62.59 - $110.3 $168,993 - $297,810	-2,700 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$34.3 - $97.98 $92,609 - $264,546	2,700 New	2,700 $207,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

Stay updated on Brr Op Co, LLC with notifications on news.